PARKERSBURG, WV – Tomorrow, Chemours will discuss its financial performance during its Q3 Quarterly Earnings Call (listeners can access the call by visiting investors.chemours.com). Chemours is a company saddled with massive debt, exposure to billions of dollars in lawsuits and remediation obligations, mounting defense costs related to ongoing litigation, and declining profitability and cash flow. “Chemours’… Read More

The credit ratings agency Moody’s has evaluated Chemours. Moody’s concluded that “a pattern of adverse [PFOA] jury decisions could heighten the risk that a meaningful liability accrues to Chemours related to this problem.” Other constraints include:

High financial leverage;
A high anticipated dividend payout relative to earnings and cash flow…… Read More